loxoprofen 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
anti-inflammatory agents, ibuprofen derivatives 1615 68767-14-6

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • loxoprofen sodium hydrate
  • loxonin
  • loxoprofen
  • loxoprofen sodium
  • sodium loxoprofen
  • Molecular weight: 246.31
  • Formula: C15H18O3
  • CLOGP: 1.97
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 1
  • TPSA: 54.37
  • ALOGS: -3.57
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2B,AXL,BRAF,CDK5,CDK9,EIF2AK3,ERBB2,GRK2,ITK,MAPK7,PDK1,PDK2,PDK4,PRKDC 14
kinase-selectivity-class AXL,EIF2AK3,GRK2 3
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
Jan. 23, 2006 PMDA Lead Chemical Co., Ltd.

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Platelet count decreased 391.27 19.37 251 13847 136718 90477631
Interstitial lung disease 383.43 19.37 202 13896 76203 90538146
Hepatic function abnormal 277.34 19.37 138 13960 46150 90568199
Neutrophil count decreased 201.19 19.37 130 13968 71402 90542947
Malignant neoplasm progression 195.02 19.37 149 13949 106721 90507628
Osteonecrosis of jaw 158.82 19.37 90 14008 39013 90575336
Anaemia 156.99 19.37 231 13867 352571 90261778
White blood cell count decreased 148.34 19.37 155 13943 166954 90447395
Drug eruption 126.53 19.37 75 14023 35332 90579017
Disseminated intravascular coagulation 116.58 19.37 60 14038 21478 90592871
Cerebral infarction 112.82 19.37 63 14035 26533 90587816
Fatigue 104.13 19.37 26 14072 1153997 89460352
Erythema multiforme 102.45 19.37 46 14052 12200 90602149
Decreased appetite 99.98 19.37 196 13902 376344 90238005
Drug ineffective 93.31 19.37 50 14048 1384248 89230101
Gastrointestinal perforation 92.24 19.37 32 14066 4300 90610049
Altered state of consciousness 90.28 19.37 58 14040 31474 90582875
Spinal compression fracture 87.13 19.37 44 14054 15134 90599215
Renal impairment 83.26 19.37 92 14006 105329 90509020
Pyrexia 78.54 19.37 253 13845 660232 89954117
Enterocolitis 77.05 19.37 36 14062 10454 90603895
Cardiac failure 73.72 19.37 88 14010 109408 90504941
Upper respiratory tract inflammation 69.74 19.37 23 14075 2649 90611700
Febrile neutropenia 69.21 19.37 103 13995 158246 90456103
Hypoalbuminaemia 65.62 19.37 37 14061 15860 90598489
Joint swelling 62.59 19.37 4 14094 503296 90111053
Drug intolerance 57.35 19.37 3 14095 447588 90166761
Pneumonia bacterial 56.15 19.37 31 14067 12759 90601590
Iron deficiency anaemia 54.43 19.37 38 14060 23624 90590725
Lymphocyte count decreased 49.25 19.37 42 14056 35008 90579341
Drug hypersensitivity 48.94 19.37 7 14091 463602 90150747
Ileus 48.75 19.37 31 14067 16515 90597834
Aspartate aminotransferase increased 47.90 19.37 69 14029 102868 90511481
Peripheral swelling 46.62 19.37 5 14093 413101 90201248
Peritonitis 46.15 19.37 32 14066 19673 90594676
Haemorrhage subcutaneous 46.05 19.37 18 14080 3378 90610971
Drug-induced liver injury 45.67 19.37 63 14035 90255 90524094
Femoral neck fracture 45.46 19.37 25 14073 10208 90604141
Ascites 45.37 19.37 46 14052 47694 90566655
Swelling 45.00 19.37 6 14092 419052 90195297
Enteritis infectious 44.28 19.37 16 14082 2419 90611930
Pain 43.37 19.37 55 14043 996286 89618063
Alanine aminotransferase increased 42.00 19.37 70 14028 118268 90496081
Herpes zoster 41.94 19.37 62 14036 94582 90519767
Pulmonary toxicity 40.06 19.37 24 14074 11507 90602842
Pneumocystis jirovecii pneumonia 39.04 19.37 30 14068 21586 90592763
Gastroenteritis 38.98 19.37 34 14064 29195 90585154
Contraindicated product administered 38.45 19.37 3 14095 320136 90294213
Atypical femur fracture 37.98 19.37 19 14079 6402 90607947
Fulminant type 1 diabetes mellitus 37.42 19.37 11 14087 867 90613482
Subarachnoid haemorrhage 37.14 19.37 27 14071 17877 90596472
Immune-mediated enterocolitis 37.03 19.37 17 14081 4740 90609609
Stevens-Johnson syndrome 36.84 19.37 33 14065 29343 90585006
Pharyngitis 36.48 19.37 29 14069 21918 90592431
Colon cancer 36.02 19.37 22 14076 10922 90603427
Blood pressure decreased 36.01 19.37 51 14047 74844 90539505
Melaena 35.77 19.37 35 14063 34762 90579587
Haemoglobin decreased 35.44 19.37 78 14020 161878 90452471
Physical deconditioning 34.43 19.37 13 14085 2222 90612127
Pleural effusion 34.20 19.37 62 14036 111929 90502420
Breast cancer 34.19 19.37 42 14056 53719 90560630
Paronychia 34.03 19.37 19 14079 7987 90606362
Pulmonary alveolar haemorrhage 33.29 19.37 17 14081 5981 90608368
Asteatosis 32.33 19.37 6 14092 59 90614290
Dyslalia 30.62 19.37 9 14089 709 90613640
Osteomyelitis 30.49 19.37 29 14069 27817 90586532
Palmar-plantar erythrodysaesthesia syndrome 30.34 19.37 29 14069 27994 90586355
Alopecia 30.16 19.37 20 14078 495051 90119298
Renal disorder 29.79 19.37 33 14065 37826 90576523
Weight increased 29.61 19.37 14 14084 417913 90196436
Blood creatine phosphokinase increased 29.11 19.37 31 14067 33992 90580357
Hyperuricaemia 28.71 19.37 16 14082 6703 90607646
Malaise 28.60 19.37 172 13926 585814 90028535
Dehydration 28.14 19.37 80 14018 194367 90419982
Heat illness 28.01 19.37 7 14091 298 90614051
Purpura 27.77 19.37 21 14077 14757 90599592
Malignant pleural effusion 27.58 19.37 12 14086 2952 90611397
Toxic encephalopathy 27.38 19.37 17 14081 8682 90605667
Enterocolitis viral 26.91 19.37 7 14091 350 90613999
Pyelonephritis 26.84 19.37 24 14074 21292 90593057
Lymphangiosis carcinomatosa 26.76 19.37 10 14088 1662 90612687
Hypothyroidism 26.76 19.37 37 14061 53090 90561259
Hypopituitarism 26.30 19.37 10 14088 1743 90612606
Immune-mediated hepatic disorder 26.08 19.37 10 14088 1782 90612567
Mobility decreased 25.94 19.37 4 14094 250730 90363619
Duodenal ulcer haemorrhage 25.92 19.37 11 14087 2545 90611804
Constipation 25.87 19.37 99 13999 280296 90334053
Liver abscess 25.68 19.37 12 14086 3484 90610865
Familial mediterranean fever 25.66 19.37 5 14093 65 90614284
Hypersensitivity 25.56 19.37 20 14078 454657 90159692
Concomitant disease aggravated 25.33 19.37 18 14080 11500 90602849
Gastric ulcer 25.26 19.37 26 14072 27422 90586927
Liver disorder 24.95 19.37 57 14041 121212 90493137
Tumour haemorrhage 24.57 19.37 10 14088 2084 90612265
Blood bilirubin increased 24.53 19.37 32 14066 43438 90570911
Pericarditis 24.39 19.37 6 14092 270145 90344204
Abdominal discomfort 24.39 19.37 23 14075 477305 90137044
Sinusitis 23.52 19.37 12 14086 343076 90271273
Product use issue 23.44 19.37 11 14087 329908 90284441
Lymphoproliferative disorder 23.42 19.37 12 14086 4250 90610099
Large intestine perforation 23.28 19.37 16 14082 9696 90604653
Depressed level of consciousness 23.11 19.37 41 14057 72743 90541606
Gamma-glutamyltransferase increased 23.08 19.37 29 14069 37923 90576426
Discomfort 23.07 19.37 7 14091 274328 90340021
Systemic lupus erythematosus 22.88 19.37 14 14084 361882 90252467
Psoriatic arthropathy 22.82 19.37 4 14094 228331 90386018
Gastrointestinal disorder 22.60 19.37 6 14092 256681 90357668
Cholangitis 22.52 19.37 14 14084 7168 90607181
Subacute hepatic failure 22.50 19.37 5 14093 127 90614222
Small intestinal perforation 21.91 19.37 9 14089 1920 90612429
Rheumatoid arthritis 21.60 19.37 15 14083 362599 90251750
Femur fracture 21.58 19.37 31 14067 46051 90568298
Aortitis 21.33 19.37 8 14090 1342 90613007
Cancer pain 21.16 19.37 11 14087 4014 90610335
Eczema 21.10 19.37 33 14065 52837 90561512
Cerebral haemorrhage 20.39 19.37 26 14072 34496 90579853
Blood cholesterol increased 20.02 19.37 4 14094 208008 90406341
Malignant ascites 20.00 19.37 7 14091 965 90613384
Shock haemorrhagic 19.96 19.37 16 14082 12229 90602120
Pneumonia 19.84 19.37 168 13930 637891 89976458
Tumour necrosis 19.80 19.37 7 14091 994 90613355
Asthenia 19.67 19.37 33 14065 533718 90080631

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Interstitial lung disease 480.61 16.66 299 12809 78163 42530064
Hepatic function abnormal 221.85 16.66 158 12950 51409 42556818
Malignant neoplasm progression 216.61 16.66 213 12895 108187 42500040
Platelet count decreased 211.97 16.66 236 12872 138345 42469882
White blood cell count decreased 116.41 16.66 156 12952 110240 42497987
Decreased appetite 100.53 16.66 198 12910 192939 42415288
Liver disorder 96.37 16.66 87 13021 39557 42568670
Neutrophil count decreased 94.94 16.66 107 13001 63308 42544919
Drug ineffective 90.03 16.66 41 13067 630156 41978071
Drug eruption 73.16 16.66 59 13049 23016 42585211
Osteonecrosis of jaw 69.67 16.66 53 13055 18996 42589231
Fatigue 65.80 16.66 26 13082 435615 42172612
Renal impairment 64.61 16.66 119 12989 110109 42498118
Disseminated intravascular coagulation 61.38 16.66 55 13053 24739 42583488
Pyrexia 58.86 16.66 258 12850 393784 42214443
Stomatitis 57.39 16.66 74 13034 50255 42557972
Cholangitis 46.33 16.66 33 13075 10694 42597533
Pancreatic abscess 46.23 16.66 11 13097 187 42608040
Radiation pneumonitis 46.02 16.66 21 13087 2912 42605315
Malaise 44.67 16.66 155 12953 212001 42396226
Gastric ulcer haemorrhage 44.14 16.66 26 13082 6101 42602126
Asthenia 43.57 16.66 16 13092 280777 42327450
Gastric ulcer 42.24 16.66 39 13069 18223 42590004
Aspartate aminotransferase increased 41.07 16.66 80 13028 77083 42531144
Confusional state 40.10 16.66 3 13105 167594 42440633
Cerebral infarction 38.97 16.66 48 13060 31121 42577106
Anaemia 38.33 16.66 179 12929 280099 42328128
Drug-induced liver injury 37.09 16.66 52 13056 38221 42570006
Non-small cell lung cancer 35.55 16.66 21 13087 4953 42603274
Lymphangiosis carcinomatosa 35.53 16.66 13 13095 1024 42607203
Delirium 34.96 16.66 60 13048 52459 42555768
Erythema multiforme 34.81 16.66 27 13081 9950 42598277
Pneumonia aspiration 34.38 16.66 58 13050 50020 42558207
C-reactive protein increased 33.94 16.66 66 13042 63494 42544733
Immune-mediated enterocolitis 32.99 16.66 21 13087 5656 42602571
Toxicity to various agents 32.38 16.66 15 13093 229121 42379106
Gastrointestinal perforation 32.22 16.66 19 13089 4467 42603760
Altered state of consciousness 31.75 16.66 42 13066 29217 42579010
Product dose omission issue 31.29 16.66 5 13103 154360 42453867
Upper respiratory tract inflammation 31.09 16.66 14 13094 1882 42606345
Enterocolitis 30.64 16.66 25 13083 9904 42598323
Adrenal insufficiency 30.11 16.66 33 13075 18891 42589336
Duodenal ulcer 29.91 16.66 27 13081 12252 42595975
Blood lactate dehydrogenase increased 29.17 16.66 38 13070 26043 42582184
Fulminant type 1 diabetes mellitus 28.58 16.66 12 13096 1362 42606865
Spinal compression fracture 27.75 16.66 21 13087 7462 42600765
Alanine aminotransferase increased 27.37 16.66 74 13034 88332 42519895
Hypothyroidism 27.30 16.66 41 13067 32043 42576184
Hypotension 26.69 16.66 24 13084 257607 42350620
Pneumonia bacterial 26.08 16.66 28 13080 15664 42592563
Hepatocellular carcinoma 26.06 16.66 21 13087 8173 42600054
Death 25.69 16.66 68 13040 471117 42137110
Adrenocorticotropic hormone deficiency 25.31 16.66 11 13097 1359 42606868
Blood bilirubin increased 25.19 16.66 46 13062 42206 42566021
Pulmonary toxicity 25.05 16.66 21 13087 8634 42599593
Pharyngitis 24.56 16.66 21 13087 8869 42599358
Rhinitis allergic 24.31 16.66 15 13093 3827 42604400
Peritonitis 23.77 16.66 29 13079 18604 42589623
Anxiety 23.66 16.66 4 13104 118556 42489671
Hyperuricaemia 23.50 16.66 21 13087 9403 42598824
Hypopituitarism 23.19 16.66 13 13095 2778 42605449
Off label use 22.89 16.66 110 12998 638225 41970002
Cancer pain 22.75 16.66 14 13094 3553 42604674
Pneumonia 22.55 16.66 213 12895 421936 42186291
Dyspnoea 22.54 16.66 66 13042 442555 42165672
Rash 21.97 16.66 153 12955 276801 42331426
Cholangitis sclerosing 21.86 16.66 11 13097 1891 42606336
Immune-mediated hepatic disorder 21.68 16.66 12 13096 2502 42605725
Haemorrhage subcutaneous 21.11 16.66 12 13096 2634 42605593
Colon cancer 21.08 16.66 20 13088 9661 42598566
Duodenal perforation 20.34 16.66 10 13098 1636 42606591
Prescribed underdose 20.06 16.66 20 13088 10262 42597965
Infective spondylitis 19.90 16.66 6 13102 258 42607969
Hypoalbuminaemia 19.44 16.66 24 13084 15586 42592641
Palmar-plantar erythrodysaesthesia syndrome 18.51 16.66 27 13081 20555 42587672
Thrombophlebitis migrans 17.91 16.66 6 13102 364 42607863
Completed suicide 17.68 16.66 4 13104 96461 42511766
Chronic gastritis 17.63 16.66 10 13098 2187 42606040
Tumour haemorrhage 17.60 16.66 12 13096 3626 42604601
Injection site dermatitis 17.11 16.66 3 13105 9 42608218
Product use in unapproved indication 17 16.66 19 13089 184437 42423790
Hypocalcaemia 16.91 16.66 32 13076 30141 42578086
Eczema asteatotic 16.72 16.66 6 13102 447 42607780
Pericarditis malignant 16.70 16.66 4 13104 70 42608157

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Interstitial lung disease 849.52 15.99 493 27307 138841 110422658
Platelet count decreased 600.41 15.99 482 27318 229961 110331538
Hepatic function abnormal 480.91 15.99 292 27508 89003 110472496
Malignant neoplasm progression 426.50 15.99 352 27448 174215 110387284
Neutrophil count decreased 280.86 15.99 237 27563 120704 110440795
White blood cell count decreased 271.91 15.99 311 27489 229079 110332420
Osteonecrosis of jaw 210.59 15.99 138 27662 47879 110513620
Decreased appetite 191.86 15.99 390 27410 475456 110086043
Drug eruption 182.83 15.99 132 27668 53527 110507972
Disseminated intravascular coagulation 174.59 15.99 116 27684 41170 110520329
Anaemia 173.44 15.99 407 27393 546679 110014820
Drug ineffective 168.05 15.99 87 27713 1520453 109041046
Fatigue 166.33 15.99 50 27750 1215908 109345591
Renal impairment 141.68 15.99 204 27596 188241 110373258
Cerebral infarction 131.48 15.99 107 27693 51731 110509768
Pyrexia 131.14 15.99 508 27292 897757 109663742
Erythema multiforme 123.80 15.99 73 27727 21024 110540475
Gastrointestinal perforation 116.11 15.99 50 27750 7406 110554093
Spinal compression fracture 103.64 15.99 62 27738 18330 110543169
Altered state of consciousness 100.16 15.99 96 27704 57530 110503969
Enterocolitis 99.37 15.99 61 27739 18888 110542611
Confusional state 97.25 15.99 5 27795 468675 110092824
Upper respiratory tract inflammation 94.24 15.99 37 27763 4334 110557165
Liver disorder 88.41 15.99 141 27659 142102 110419397
Aspartate aminotransferase increased 82.69 15.99 146 27654 159790 110401709
Drug intolerance 79.35 15.99 6 27794 406506 110154993
Hypoalbuminaemia 75.98 15.99 61 27739 28913 110532586
Joint swelling 75.04 15.99 11 27789 442834 110118665
Pneumonia bacterial 74.69 15.99 58 27742 26203 110535296
Cardiac failure 73.24 15.99 152 27648 187474 110374025
Drug hypersensitivity 73.09 15.99 13 27787 454077 110107422
Asthenia 69.21 15.99 44 27756 688955 109872544
Peripheral swelling 68.54 15.99 10 27790 404024 110157475
Drug-induced liver injury 66.48 15.99 113 27687 119954 110441545
Peritonitis 65.70 15.99 59 27741 32548 110528951
Gastric ulcer 64.79 15.99 64 27736 39763 110521736
Cholangitis 64.49 15.99 44 27756 16291 110545208
Immune-mediated enterocolitis 64.40 15.99 37 27763 10148 110551351
Pain 64.16 15.99 88 27712 954867 109606632
Pulmonary toxicity 63.50 15.99 45 27755 17701 110543798
Febrile neutropenia 62.24 15.99 198 27602 316569 110244930
Fulminant type 1 diabetes mellitus 61.70 15.99 23 27777 2340 110559159
Alanine aminotransferase increased 61.58 15.99 140 27660 183633 110377866
Swelling 61.16 15.99 8 27792 351033 110210466
Lymphangiosis carcinomatosa 60.60 15.99 23 27777 2459 110559040
Haemorrhage subcutaneous 60.46 15.99 29 27771 5510 110555989
Pharyngitis 59.85 15.99 50 27750 25048 110536451
Arthropathy 59.82 15.99 3 27797 287519 110273980
Product dose omission issue 59.38 15.99 6 27794 321776 110239723
Pneumonia aspiration 58.15 15.99 86 27714 81147 110480352
Colon cancer 57.23 15.99 41 27759 16402 110545097
Radiation pneumonitis 56.45 15.99 26 27774 4510 110556989
Non-small cell lung cancer 56.06 15.99 31 27769 7904 110553595
Gastric ulcer haemorrhage 54.21 15.99 33 27767 10061 110551438
Ileus 53.02 15.99 51 27749 30678 110530821
Malaise 52.53 15.99 318 27482 671501 109889998
Hyperuricaemia 52.34 15.99 37 27763 14494 110547005
Blood bilirubin increased 50.92 15.99 78 27722 75894 110485605
Pneumocystis jirovecii pneumonia 50.58 15.99 58 27742 42677 110518822
Femoral neck fracture 49.96 15.99 34 27766 12533 110548966
Iron deficiency anaemia 48.18 15.99 49 27751 31510 110529989
Hypopituitarism 47.96 15.99 23 27777 4367 110557132
Hypersensitivity 47.58 15.99 21 27779 403977 110157522
Renal disorder 46.89 15.99 60 27740 49419 110512080
Pneumonia 46.77 15.99 378 27422 876336 109685163
Therapeutic product effect decreased 46.55 15.99 4 27796 244312 110317187
Hypothyroidism 46.28 15.99 73 27727 72826 110488673
Herpes zoster 46.07 15.99 91 27709 108288 110453211
Adrenal insufficiency 45.96 15.99 55 27745 42335 110519164
Contraindicated product administered 44.85 15.99 5 27795 248262 110313237
Gastroenteritis 44.81 15.99 52 27748 38748 110522751
Haemoglobin decreased 44.81 15.99 151 27649 248576 110312923
Immune-mediated hepatic disorder 44.66 15.99 22 27778 4428 110557071
Lymphocyte count decreased 44.46 15.99 63 27737 57180 110504319
Enteritis infectious 44.43 15.99 21 27779 3861 110557638
Pleural effusion 44.35 15.99 121 27679 177588 110383911
Cancer pain 43.88 15.99 25 27775 6747 110554752
Delirium 43.16 15.99 101 27699 134924 110426575
Dyspnoea 42.43 15.99 140 27660 1106732 109454767
Blood lactate dehydrogenase increased 42.39 15.99 54 27746 44280 110517219
Adrenocorticotropic hormone deficiency 41.93 15.99 17 27783 2165 110559334
Constipation 41.47 15.99 189 27611 357597 110203902
Tumour haemorrhage 41.25 15.99 22 27778 5223 110556276
Completed suicide 41.08 15.99 6 27794 242375 110319124
Palmar-plantar erythrodysaesthesia syndrome 40.86 15.99 51 27749 40974 110520525
Duodenal ulcer 40.68 15.99 36 27764 19478 110542021
Paraesthesia 40.19 15.99 10 27790 276511 110284988
Toxicity to various agents 40.15 15.99 37 27763 480518 110080981
Stomatitis 40.10 15.99 154 27646 270088 110291411
Stevens-Johnson syndrome 40.00 15.99 54 27746 46847 110514652
Hypotension 39.59 15.99 44 27756 523805 110037694
Off label use 39.55 15.99 219 27581 1499966 109061533
Weight increased 39.15 15.99 29 27771 419615 110141884
Blood creatine phosphokinase increased 38.11 15.99 67 27733 73010 110488489
Dyslalia 37.95 15.99 14 27786 1383 110560116
Pancreatic abscess 37.69 15.99 9 27791 192 110561307
Hepatocellular carcinoma 37.55 15.99 26 27774 9854 110551645
Wheezing 37.54 15.99 9 27791 255221 110306278
Anxiety 37.48 15.99 20 27780 345058 110216441
Wound 37.07 15.99 7 27793 234430 110327069
Physical deconditioning 37.04 15.99 18 27782 3519 110557980
Product use in unapproved indication 36.72 15.99 35 27765 447342 110114157
Small intestinal perforation 36.24 15.99 19 27781 4357 110557142
Melaena 35.80 15.99 63 27737 68694 110492805
Liver abscess 35.76 15.99 23 27777 7716 110553783
Mobility decreased 35.66 15.99 8 27792 237414 110324085
Gamma-glutamyltransferase increased 35.65 15.99 59 27741 61250 110500249
Helicobacter infection 34.58 15.99 3 27797 181874 110379625
Malignant pleural effusion 34.55 15.99 18 27782 4075 110557424
Pulmonary alveolar haemorrhage 33.92 15.99 33 27767 20117 110541382
Pneumothorax 33.77 15.99 43 27757 35242 110526257
Type 2 diabetes mellitus 33.49 15.99 3 27797 177229 110384270
Alopecia 33.00 15.99 26 27774 364727 110196772
Hypocalcaemia 32.89 15.99 59 27741 65307 110496192
Pain in extremity 32.51 15.99 45 27755 487073 110074426
Ascites 32.51 15.99 72 27728 92736 110468763
Headache 32.14 15.99 114 27686 882263 109679236
Fibromyalgia 32.01 15.99 3 27797 170906 110390593
Duodenal perforation 31.75 15.99 15 27785 2755 110558744
Blood pressure decreased 31.37 15.99 81 27719 115010 110446489
Paronychia 30.48 15.99 24 27776 11057 110550442
Maternal exposure during pregnancy 30.38 15.99 13 27787 254870 110306629
Blood cholesterol increased 30.34 15.99 5 27795 184780 110376719
Atypical femur fracture 30.02 15.99 19 27781 6200 110555299
Asteatosis 29.97 15.99 8 27792 271 110561228
Chronic gastritis 29.85 15.99 18 27782 5393 110556106
Rhinitis allergic 29.52 15.99 29 27771 17893 110543606
Osteomyelitis 29.49 15.99 41 27759 36559 110524940
Large intestine perforation 29.44 15.99 28 27772 16601 110544898
Haemolytic anaemia 29.27 15.99 31 27769 20889 110540610
Discomfort 28.89 15.99 9 27791 214698 110346801
Femur fracture 28.87 15.99 45 27755 44424 110517075
Pericarditis 28.06 15.99 10 27790 219104 110342395
Musculoskeletal stiffness 27.86 15.99 18 27782 279804 110281695
Breast cancer 27.85 15.99 41 27759 38501 110522998
Gastrointestinal disorder 27.80 15.99 13 27787 241939 110319560
Nephrotic syndrome 27.80 15.99 25 27775 13806 110547693
Pyelonephritis 27.76 15.99 33 27767 25217 110536282
Abdominal discomfort 27.69 15.99 35 27765 393823 110167676
Metastases to liver 27.56 15.99 39 27761 35347 110526152
Cerebrovascular accident 27.43 15.99 6 27794 181278 110380221
Injection site dermatitis 27.33 15.99 5 27795 26 110561473
Memory impairment 26.96 15.99 8 27792 196936 110364563
Psoriatic arthropathy 26.92 15.99 8 27792 196753 110364746
Thyroiditis 26.65 15.99 18 27782 6555 110554944
Drug abuse 26.59 15.99 6 27794 177405 110384094
Eczema 26.36 15.99 57 27743 72236 110489263
Weight decreased 25.82 15.99 49 27751 468008 110093491
Dry mouth 25.81 15.99 9 27791 199939 110361560
Sinusitis 25.77 15.99 22 27778 296666 110264833
Irritable bowel syndrome 25.75 15.99 5 27795 164210 110397289
Thrombophlebitis migrans 25.70 15.99 9 27791 765 110560734
Blood urea increased 25.62 15.99 48 27752 54909 110506590
Heat illness 25.50 15.99 9 27791 783 110560716
Migraine 25.34 15.99 6 27794 171646 110389853
Eczema asteatotic 25.15 15.99 9 27791 815 110560684
Sudden hearing loss 25.13 15.99 12 27788 2257 110559242
Rheumatoid arthritis 25.08 15.99 23 27777 299590 110261909
General physical health deterioration 24.82 15.99 43 27757 425252 110136247
Infective spondylitis 24.78 15.99 8 27792 530 110560969
Small intestine ulcer 24.67 15.99 9 27791 862 110560637
Injury 24.63 15.99 7 27793 177258 110384241
Cerebral haemorrhage 24.58 15.99 52 27748 64916 110496583
Folliculitis 24.47 15.99 6 27794 167647 110393852
KL-6 increased 24.41 15.99 7 27793 310 110561189
Tumour necrosis 24.32 15.99 12 27788 2424 110559075
Therapy non-responder 24.23 15.99 5 27795 157302 110404197
Diverticulum intestinal haemorrhagic 24.12 15.99 15 27785 4748 110556751
Product use issue 23.72 15.99 26 27774 311669 110249830
Muscle spasms 23.71 15.99 21 27779 278136 110283363
Night sweats 23.44 15.99 3 27797 133980 110427519
Duodenal ulcer haemorrhage 23.39 15.99 18 27782 8019 110553480
Intentional product use issue 23.27 15.99 17 27783 247889 110313610
Meningitis 23.22 15.99 21 27779 11681 110549818
Syncope 23.09 15.99 11 27789 202525 110358974
Chest pain 22.94 15.99 37 27763 376338 110185161
Periodontitis 22.89 15.99 15 27785 5193 110556306
Immune-mediated lung disease 22.65 15.99 15 27785 5288 110556211
Loss of personal independence in daily activities 22.63 15.99 5 27795 150015 110411484
Cholangitis sclerosing 22.61 15.99 13 27787 3569 110557930
Blood alkaline phosphatase increased 22.59 15.99 53 27747 70882 110490617
Familial mediterranean fever 22.51 15.99 6 27794 202 110561297
C-reactive protein abnormal 22.46 15.99 3 27797 129692 110431807
C-reactive protein increased 22.23 15.99 111 27689 217808 110343691
Cellulitis 22.22 15.99 76 27724 125940 110435559
Metastases to bone 22.13 15.99 33 27767 31339 110530160
Subarachnoid haemorrhage 22.05 15.99 32 27768 29670 110531829
Small intestinal haemorrhage 22.02 15.99 14 27786 4604 110556895
Immune-mediated encephalitis 21.94 15.99 9 27791 1181 110560318
Systemic lupus erythematosus 21.92 15.99 19 27781 254319 110307180
Hyperkalaemia 21.46 15.99 79 27721 135717 110425782
Skin erosion 21.30 15.99 15 27785 5839 110555660
Tubulointerstitial nephritis 21.18 15.99 44 27756 54240 110507259
Enterocolitis viral 20.92 15.99 8 27792 873 110560626
Cholangitis acute 20.83 15.99 10 27790 1903 110559596
Concomitant disease aggravated 20.71 15.99 23 27777 16341 110545158
Lymphoproliferative disorder 20.65 15.99 16 27784 7202 110554297
Diarrhoea 20.58 15.99 401 27399 1139104 109422395
Gastric cancer 20.38 15.99 19 27781 10989 110550510
Toxic encephalopathy 20.32 15.99 22 27778 15192 110546307
Loss of consciousness 20.02 15.99 100 27700 196206 110365293
Dermatitis acneiform 19.90 15.99 20 27780 12675 110548824
Arthralgia 19.80 15.99 115 27685 779517 109781982
Colony stimulating factor therapy 19.55 15.99 7 27793 635 110560864
Heart rate increased 19.40 15.99 6 27794 143828 110417671
Infusion related reaction 19.23 15.99 42 27758 381120 110180379
Oculomucocutaneous syndrome 19.22 15.99 6 27794 356 110561143
Osteoarthritis 19.21 15.99 11 27789 182612 110378887
Peripheral sensory neuropathy 18.67 15.99 22 27778 16658 110544841
Depression 18.58 15.99 32 27768 317303 110244196
Blister 18.39 15.99 18 27782 227358 110334141
Shock haemorrhagic 18.28 15.99 28 27772 27219 110534280
Duodenal ulcer perforation 18.28 15.99 11 27789 177689 110383810
Mechanical ileus 18.05 15.99 8 27792 1269 110560230
Rash 18.01 15.99 298 27502 820666 109740833
Intra-abdominal haemorrhage 17.86 15.99 13 27787 5329 110556170
Exposure during pregnancy 17.73 15.99 10 27790 167414 110394085
Hepatic atrophy 17.65 15.99 6 27794 467 110561032
Diabetes mellitus 17.58 15.99 60 27740 99321 110462178
Aortitis 17.40 15.99 9 27791 2006 110559493
Immune-mediated cholangitis 17.37 15.99 7 27793 877 110560622
Balance disorder 17.35 15.99 4 27796 116556 110444943
Malignant ascites 17.29 15.99 8 27792 1402 110560097
Compression fracture 17.12 15.99 16 27784 9283 110552216
Pleurisy 17.03 15.99 18 27782 12098 110549401
Amnesia 16.97 15.99 3 27797 105405 110456094
Dehydration 16.75 15.99 124 27676 279387 110282112
Pericarditis malignant 16.59 15.99 4 27796 89 110561410
Infectious pleural effusion 16.57 15.99 12 27788 4879 110556620
Blood creatinine increased 16.46 15.99 90 27710 182799 110378700
Cytomegalovirus enterocolitis 16.36 15.99 9 27791 2272 110559227
Radius fracture 16.32 15.99 11 27789 3989 110557510
Pulmonary artery thrombosis 16.32 15.99 8 27792 1594 110559905
Organising pneumonia 16.30 15.99 19 27781 14224 110547275

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC M01AE19 MUSCULO-SKELETAL SYSTEM
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Propionic acid derivatives
ATC M02AA31 MUSCULO-SKELETAL SYSTEM
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
Antiinflammatory preparations, non-steroids for topical use
MeSH PA D000700 Analgesics
MeSH PA D000893 Anti-Inflammatory Agents
MeSH PA D000894 Anti-Inflammatory Agents, Non-Steroidal
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D018501 Antirheumatic Agents
MeSH PA D018689 Sensory System Agents
MeSH PA D018712 Analgesics, Non-Narcotic
CHEBI has role CHEBI:35475 non-steroidal anti-inflammatory drug
CHEBI has role CHEBI:35481 non-narcotic analgesic
CHEBI has role CHEBI:35493 antipyretic
CHEBI has role CHEBI:35544 EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
CHEBI has role CHEBI:35480 analgesic
CHEBI has role CHEBI:35842 antirheumatic drug
CHEBI has role CHEBI:50266 prodrug

Related Drugs by ATC class:

M01AE Propionic acid derivatives 21 drugs
M02AA Antiinflammatory preparations, non-steroids for topical use 28 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Rheumatoid arthritis indication 69896004 DOID:7148




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 4.37 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Prostaglandin G/H synthase 2 Enzyme INHIBITOR IC50 5 CHEMBL KEGG DRUG
Prostaglandin G/H synthase 1 Enzyme INHIBITOR IC50 5.19 CHEMBL KEGG DRUG

External reference:

IDSource
D08149 KEGG_DRUG
C0065199 UMLSCUI
CHEBI:31786 CHEBI
CHEMBL19299 ChEMBL_ID
DB09212 DRUGBANK_ID
CHEMBL66552 ChEMBL_ID
C040656 MESH_SUPPLEMENTAL_RECORD_UI
3965 PUBCHEM_CID
5410 INN_ID
80382-23-6 SECONDARY_CAS_RN
3583H0GZAP UNII
28908 RXNORM
008162 NDDF
18991000122102 SNOMEDCT_US
484071000221104 SNOMEDCT_US
3583H0GZAP INXIGHT DRUGS

Pharmaceutical products:

None